1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.
about
Vitamin D and the Epithelial to Mesenchymal TransitionCommonalities in the Association between PPARG and Vitamin D Related with Obesity and CarcinogenesisMicro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutationsDiet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal TransitionNew advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.
P2860
Q26765878-C7F064F4-214F-4A65-AA0A-CB2616589CAEQ28070220-6E77E63E-C2E1-4F2D-AB20-787462302840Q36494718-048000FE-BD1A-4CCD-909F-63FC12A34DAAQ36524235-4DB9EE34-A721-4C32-AF18-65A5C6CFAC84Q36729586-075BFD60-ACAF-4444-8AE1-4E6E1DCB6164Q37210064-D48EFE2D-6977-42FE-B784-82E40A649786Q38717167-2CCF3EE4-794D-4889-A8C6-AB1918F4AE7BQ41694103-9F716F25-0404-4EAE-B9C5-842B090C191DQ42679595-A3C828A6-DEA7-4947-8D0A-F231C7D415D8
P2860
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@en
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@nl
type
label
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@en
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@nl
prefLabel
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@en
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@nl
P2093
P2860
P356
P1433
P1476
1,25-Dihydroxyvitamin D3 (1,25 ...... ,25(OH)2D3 in NSCLC Treatment.
@en
P2093
Alissa Verone
Maochun Qin
Moray Campbell
Pamela A Hershberger
Santosh Kumar Upadhyay
Suzanne Shoemaker
P2860
P304
P356
10.3390/CANCERS5041504
P577
2013-11-08T00:00:00Z